PTPRT
Basic information
Region (hg38): 20:42072752-43189970
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTPRT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 18 | 19 | 37 | |||
missense | 70 | 83 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | 1 | 3 | ||
non coding | 5 | |||||
Total | 0 | 1 | 71 | 24 | 30 |
Variants in PTPRT
This is a list of pathogenic ClinVar variants found in the PTPRT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-42079239-C-T | Benign (Feb 18, 2020) | |||
20-42080915-T-C | PTPRT-related disorder | Likely benign (Dec 11, 2019) | ||
20-42081914-G-A | Abnormality of neuronal migration | Benign (Oct 31, 2014) | ||
20-42081942-A-C | not specified | Uncertain significance (Dec 28, 2023) | ||
20-42081986-C-T | not specified | Uncertain significance (Jun 16, 2023) | ||
20-42082003-C-T | PTPRT-related disorder | Likely benign (Nov 01, 2022) | ||
20-42084674-G-A | PTPRT-related disorder | Benign (May 23, 2019) | ||
20-42084700-C-T | not specified | Uncertain significance (Sep 22, 2022) | ||
20-42084713-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
20-42084721-T-A | PTPRT-related disorder | Uncertain significance (Sep 25, 2024) | ||
20-42084745-C-G | PTPRT-associated neurodevelopmentaldisorder | Uncertain significance (Sep 03, 2021) | ||
20-42084780-C-T | PTPRT-related disorder | Likely benign (Sep 05, 2019) | ||
20-42084781-G-A | Intellectual disability | Uncertain significance (-) | ||
20-42084793-G-A | not specified | Uncertain significance (Apr 13, 2022) | ||
20-42085729-C-T | not specified | Uncertain significance (May 05, 2023) | ||
20-42085747-C-T | not specified | Uncertain significance (Feb 12, 2024) | ||
20-42085817-A-T | PTPRT-related disorder | Likely benign (Apr 11, 2019) | ||
20-42085820-C-T | not specified | Uncertain significance (Sep 27, 2022) | ||
20-42085839-G-A | PTPRT-related disorder | Benign (Oct 17, 2019) | ||
20-42098498-C-T | not specified | Uncertain significance (Mar 24, 2023) | ||
20-42098522-T-C | PTPRT-related disorder | Likely benign (May 02, 2018) | ||
20-42098528-C-G | not specified | Uncertain significance (Aug 12, 2021) | ||
20-42098534-C-T | not specified | Uncertain significance (Mar 28, 2024) | ||
20-42102135-C-T | Likely benign (Jul 26, 2018) | |||
20-42102191-C-T | not specified | Uncertain significance (May 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTPRT | protein_coding | protein_coding | ENST00000373187 | 31 | 1117219 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 8.55e-8 | 124791 | 0 | 11 | 124802 | 0.0000441 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.14 | 612 | 873 | 0.701 | 0.0000539 | 9387 |
Missense in Polyphen | 213 | 381.02 | 0.55902 | 4044 | ||
Synonymous | -0.355 | 353 | 345 | 1.02 | 0.0000225 | 2827 |
Loss of Function | 7.48 | 8 | 80.3 | 0.0996 | 0.00000460 | 816 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000300 | 0.0000300 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000592 | 0.0000556 |
Finnish | 0.0000931 | 0.0000928 |
European (Non-Finnish) | 0.0000547 | 0.0000530 |
Middle Eastern | 0.0000592 | 0.0000556 |
South Asian | 0.00 | 0.00 |
Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in both signal transduction and cellular adhesion in the CNS.;
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.0898
- rvis_EVS
- -1.03
- rvis_percentile_EVS
- 7.87
Haploinsufficiency Scores
- pHI
- 0.397
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.552
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.268
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ptprt
- Phenotype
- homeostasis/metabolism phenotype; neoplasm;
Gene ontology
- Biological process
- protein dephosphorylation;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;negative regulation of cell migration;peptidyl-tyrosine dephosphorylation;cellular response to interleukin-6;negative regulation of STAT cascade;peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity
- Cellular component
- plasma membrane;integral component of plasma membrane;cell surface;integral component of membrane
- Molecular function
- protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding;beta-catenin binding;protein phosphatase binding;protein homodimerization activity;alpha-catenin binding;gamma-catenin binding;cadherin binding;delta-catenin binding;STAT family protein binding